Asgard Therapeutics selects Exothera to bring their viral vector-based immunotherapy candidate AT-108 to clinical trial stage
June 11, 2024
June 11, 2024
June 5, 2024
May 15, 2024
May 15, 2024
May 15, 2024
May 14, 2024
May 2, 2024
April 22, 2024
March 12, 2024
October 9, 2024
Regulatory and Compliance excellence recognized for innovation across the product development lifecycle ProPharma, a leading global provider of regula...
October 8, 2024
Exothera is a GMP-certified CDMO offering a complete range of services for viral vectors, RNA therapeutics, and vaccines. From early discovery to comm...
October 8, 2024
LNP developers now have access to bench-to-patient lipid synthesis support from a single partner ABITEC Corporation, a global leader in specialty lipi...
Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225